CD38, BCL-2, PD-1, and PD-1L expression in nodal peripheral T-cell lymphoma: Possible biomarkers for novel targeted therapies?

F. Zaja, V. Tabanelli, C. Agostinelli, A. Calleri, A. Chiappella, M. Varettoni, P. Luigi Zinzani, S. Volpetti, E. Sabattini, R. Fanin, S. A. Pileri

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)E1-E2
JournalAmerican Journal of Hematology
Volume92
Issue number1
DOIs
Publication statusPublished - Jan 1 2017

Keywords

  • ADP-ribosyl Cyclase 1/biosynthesis
  • B7-H1 Antigen/biosynthesis
  • Drug Delivery Systems/methods
  • Female
  • Gene Expression Regulation, Neoplastic
  • Humans
  • Lymphoma, T-Cell, Peripheral/drug therapy/metabolism/pathology
  • Male
  • Membrane Glycoproteins/biosynthesis
  • Programmed Cell Death 1 Receptor/biosynthesis
  • Proto-Oncogene Proteins c-bcl-2/biosynthesis

Cite this